India

India

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.93 (2.57 - 3.29) 2019 Modelled IHME
2.96 (2.60 - 3.34) 2018 Modelled IHME
3 (2.63 - 3.39) 2017 Modelled IHME
3.02 (2.65 - 3.40) 2016 Modelled IHME
3.06 (2.67 - 3.43) 2015 Modelled IHME
3.11 (2.71 - 3.50) 2014 Modelled IHME
3.2 (2.79 - 3.59) 2013 Modelled IHME
3.28 (2.85 - 3.69) 2012 Modelled IHME
3.36 (2.92 - 3.79) 2011 Modelled IHME
3.42 (2.97 - 3.86) 2010 Modelled IHME
3.45 (3 - 3.90) 2009 Modelled IHME
3.48 (3.03 - 3.93) 2008 Modelled IHME
3.5 (3.05 - 3.95) 2007 Modelled IHME
3.52 (3.07 - 3.97) 2006 Modelled IHME
3.54 (3.09 - 3.99) 2005 Modelled IHME
3.55 (3.09 - 4.02) 2004 Modelled IHME
3.56 (3.10 - 4.04) 2003 Modelled IHME
3.58 (3.11 - 4.06) 2002 Modelled IHME
3.59 (3.12 - 4.07) 2001 Modelled IHME
3.59 (3.13 - 4.09) 2000 Modelled IHME
3.6 (3.14 - 4.10) 1999 Modelled IHME
3.61 (3.14 - 4.10) 1998 Modelled IHME
3.62 (3.14 - 4.11) 1997 Modelled IHME
3.63 (3.16 - 4.12) 1996 Modelled IHME
3.64 (3.17 - 4.14) 1995 Modelled IHME
3.65 (3.18 - 4.14) 1994 Modelled IHME
3.66 (3.18 - 4.17) 1993 Modelled IHME
3.68 (3.18 - 4.20) 1992 Modelled IHME
3.69 (3.20 - 4.22) 1991 Modelled IHME
3.7 (3.20 - 4.24) 1990 Modelled IHME
1.65 (1.33 - 2.02) 2015 Modelled WHO
3.07 (3.17 - 4.24) 2009 Modelled Batham et al, 2009
1 2001 Modelled Lodha et al, 2001
3.7 2014 Modelled National Centre for Disease Control, 2014
1.46 (1.44 - 1.47) 2013 Modelled Schweitzer et al, 2015
4 1996 Modelled Tandon et al, 1996
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.52 (0.42 - 0.63) 2019 Modelled IHME
0.55 (0.45 - 0.67) 2018 Modelled IHME
0.59 (0.48 - 0.71) 2017 Modelled IHME
0.62 (0.51 - 0.75) 2016 Modelled IHME
0.67 (0.54 - 0.80) 2015 Modelled IHME
0.81 (0.66 - 0.96) 2014 Modelled IHME
1.05 (0.86 - 1.26) 2013 Modelled IHME
1.35 (1.09 - 1.61) 2012 Modelled IHME
1.63 (1.32 - 1.95) 2011 Modelled IHME
1.83 (1.48 - 2.20) 2010 Modelled IHME
1.98 (1.60 - 2.39) 2009 Modelled IHME
2.12 (1.72 - 2.56) 2008 Modelled IHME
2.25 (1.83 - 2.71) 2007 Modelled IHME
2.33 (1.90 - 2.82) 2006 Modelled IHME
2.37 (1.93 - 2.86) 2005 Modelled IHME
2.37 (1.93 - 2.87) 2004 Modelled IHME
2.37 (1.92 - 2.88) 2003 Modelled IHME
2.37 (1.92 - 2.89) 2002 Modelled IHME
2.37 (1.92 - 2.89) 2001 Modelled IHME
2.37 (1.92 - 2.90) 2000 Modelled IHME
2.36 (1.91 - 2.89) 1999 Modelled IHME
2.35 (1.90 - 2.87) 1998 Modelled IHME
2.34 (1.89 - 2.85) 1997 Modelled IHME
2.33 (1.88 - 2.84) 1996 Modelled IHME
2.33 (1.88 - 2.84) 1995 Modelled IHME
2.33 (1.88 - 2.84) 1994 Modelled IHME
2.33 (1.88 - 2.85) 1993 Modelled IHME
2.33 (1.88 - 2.85) 1992 Modelled IHME
2.33 (1.87 - 2.86) 1991 Modelled IHME
2.34 (1.86 - 2.86) 1990 Modelled IHME
0.51 (0.38 - 0.65) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
35 (31 - 40) 2019 Modelled IHME
35 (31 - 40) 2018 Modelled IHME
36 (32 - 40) 2017 Modelled IHME
37 (33 - 41) 2016 Modelled IHME
38 (34 - 42) 2015 Modelled IHME
38 (34 - 42) 2014 Modelled IHME
38 (34 - 42) 2013 Modelled IHME
38 (34 - 43) 2012 Modelled IHME
38 (34 - 43) 2011 Modelled IHME
39 (34 - 43) 2010 Modelled IHME
39 (35 - 43) 2009 Modelled IHME
39 (35 - 43) 2008 Modelled IHME
39 (35 - 43) 2007 Modelled IHME
39 (35 - 43) 2006 Modelled IHME
39 (35 - 44) 2005 Modelled IHME
39 (35 - 44) 2004 Modelled IHME
39 (35 - 44) 2003 Modelled IHME
39 (35 - 44) 2002 Modelled IHME
39 (35 - 44) 2001 Modelled IHME
39 (35 - 44) 2000 Modelled IHME
40 (36 - 44) 1999 Modelled IHME
40 (36 - 44) 1998 Modelled IHME
40 (36 - 45) 1997 Modelled IHME
41 (36 - 45) 1996 Modelled IHME
41 (36 - 45) 1995 Modelled IHME
41 (37 - 46) 1994 Modelled IHME
41 (37 - 46) 1993 Modelled IHME
41 (37 - 46) 1992 Modelled IHME
41 (37 - 46) 1991 Modelled IHME
41 (37 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
54 2018 Survey/reported WHO/UNICEF
54 2017 Survey/reported WHO/UNICEF
47 2016 Survey/reported WHO/UNICEF
44 2015 Survey/reported WHO/UNICEF
41 2014 Survey/reported WHO/UNICEF
37 2013 Survey/reported WHO/UNICEF
23 2012 Survey/reported WHO/UNICEF
8 2011 Survey/reported WHO/UNICEF
8 2010 Survey/reported WHO/UNICEF
8 2009 Survey/reported WHO/UNICEF
8 2008 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
89 2018 Survey/reported WHO/UNICEF
89 2017 Survey/reported WHO/UNICEF
88 2016 Survey/reported WHO/UNICEF
87 2015 Survey/reported WHO/UNICEF
79 2014 Survey/reported WHO/UNICEF
70 2013 Survey/reported WHO/UNICEF
73 2012 Survey/reported WHO/UNICEF
44 2011 Survey/reported WHO/UNICEF
38 2010 Survey/reported WHO/UNICEF
37 2009 Survey/reported WHO/UNICEF
29 2008 Survey/reported WHO/UNICEF
6 2007 Survey/reported WHO/UNICEF
6 2006 Survey/reported WHO/UNICEF
8 2005 Survey/reported WHO/UNICEF
6 2004 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
86 (63 - 133) 2015 Survey/reported Larney S et al, 2017
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2008
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.83 (0.67 - 1.02) 2019 Modelled IHME
0.82 (0.66 - 1.02) 2018 Modelled IHME
0.81 (0.65 - 1) 2017 Modelled IHME
0.79 (0.64 - 0.98) 2016 Modelled IHME
0.78 (0.62 - 0.96) 2015 Modelled IHME
0.78 (0.63 - 0.96) 2014 Modelled IHME
0.78 (0.63 - 0.96) 2013 Modelled IHME
0.78 (0.63 - 0.96) 2012 Modelled IHME
0.78 (0.63 - 0.96) 2011 Modelled IHME
0.78 (0.63 - 0.96) 2010 Modelled IHME
0.77 (0.62 - 0.95) 2009 Modelled IHME
0.74 (0.60 - 0.92) 2008 Modelled IHME
0.71 (0.58 - 0.88) 2007 Modelled IHME
0.69 (0.55 - 0.85) 2006 Modelled IHME
0.68 (0.54 - 0.83) 2005 Modelled IHME
0.68 (0.55 - 0.84) 2004 Modelled IHME
0.69 (0.55 - 0.85) 2003 Modelled IHME
0.69 (0.56 - 0.86) 2002 Modelled IHME
0.71 (0.57 - 0.87) 2001 Modelled IHME
0.72 (0.58 - 0.89) 2000 Modelled IHME
0.74 (0.59 - 0.91) 1999 Modelled IHME
0.76 (0.61 - 0.94) 1998 Modelled IHME
0.79 (0.64 - 0.97) 1997 Modelled IHME
0.81 (0.66 - 1) 1996 Modelled IHME
0.83 (0.67 - 1.03) 1995 Modelled IHME
0.84 (0.67 - 1.04) 1994 Modelled IHME
0.85 (0.67 - 1.05) 1993 Modelled IHME
0.85 (0.68 - 1.06) 1992 Modelled IHME
0.86 (0.68 - 1.07) 1991 Modelled IHME
0.86 (0.68 - 1.07) 1990 Modelled IHME
0.5 (0.40 - 0.80) 2015 Modelled Blach et al, 2017
0.7 (0.40 - 0.80) 2014 Modelled Gower et al, 2014
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.8 (0.40 - 1) 2014 Modelled Gower et al, 2014
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
3.51 (2.43 - 4.76) 2018 Modelled Goel et al, 2018
People who inject drugs (PWID)
Download
Value (%) Year Type Source
40 (33.90 - 46.10) 2015 Modelled Degenhardt L et al, 2017
44.71 (37.50 - 52.03) 2018 Modelled Goel et al, 2018
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.88 (0.21 - 1.90) 2018 Modelled Goel et al, 2018

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
20 (17 - 24) 2019 Modelled IHME
20 (17 - 24) 2018 Modelled IHME
20 (17 - 23) 2017 Modelled IHME
20 (17 - 23) 2016 Modelled IHME
19 (16 - 22) 2015 Modelled IHME
19 (17 - 22) 2014 Modelled IHME
19 (16 - 22) 2013 Modelled IHME
19 (16 - 22) 2012 Modelled IHME
19 (16 - 22) 2011 Modelled IHME
19 (16 - 22) 2010 Modelled IHME
19 (16 - 22) 2009 Modelled IHME
19 (16 - 22) 2008 Modelled IHME
19 (16 - 22) 2007 Modelled IHME
19 (16 - 21) 2006 Modelled IHME
18 (16 - 21) 2005 Modelled IHME
18 (16 - 21) 2004 Modelled IHME
18 (16 - 21) 2003 Modelled IHME
18 (16 - 21) 2002 Modelled IHME
18 (16 - 21) 2001 Modelled IHME
18 (15 - 21) 2000 Modelled IHME
18 (15 - 21) 1999 Modelled IHME
18 (15 - 21) 1998 Modelled IHME
18 (15 - 21) 1997 Modelled IHME
18 (15 - 20) 1996 Modelled IHME
17 (15 - 20) 1995 Modelled IHME
17 (15 - 20) 1994 Modelled IHME
17 (15 - 20) 1993 Modelled IHME
17 (14 - 20) 1992 Modelled IHME
17 (14 - 20) 1991 Modelled IHME
17 (14 - 20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (63 - 133) 2015 Survey/reported Larney S et al, 2017
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2008
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
2.93 (%)
2019
(2.57 - 3.29(%))
IHME
HCV (RNA/cAg+)
0.83 (%)
2019
(0.67 - 1.02(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
110,372
2019
(89,416 - 134,741)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
66,699
2019
(54,749 - 80,749)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.52 (%)
2019, latest modelled
(0.42 - 0.63(%))
IHME

Prevalence PWID

HCV
44.71 (%)
2018, latest modelled
(37.50 - 52.03(%))
Goel et al, 2018

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
54 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
86
2015
(63 - 133)
Larney S et al, 2017
Eligible for HBV generic medicines

Resources